
Tissue bioprinting ink, often referred to as bio-ink, is a specialized material used in the field of bioprinting to create three-dimensional structures by depositing layers of living cells and supporting biomaterials.
The global Tissue Bioprinting Ink market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tissue Bioprinting Ink is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tissue Bioprinting Ink is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tissue Bioprinting Ink include CELLINK, PB Leiner, Organovo, Humabiologics, UPM Biomedicals, Innoregen, Axolotl Biosciences, Jellagen and Advanced BioMatrix (BICO), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tissue Bioprinting Ink, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Bioprinting Ink.
Report Scope
The Tissue Bioprinting Ink market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tissue Bioprinting Ink market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Bioprinting Ink manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CELLINK
PB Leiner
Organovo
Humabiologics
UPM Biomedicals
Innoregen
Axolotl Biosciences
Jellagen
Advanced BioMatrix (BICO)
RegenHU
GeSIM
CollPlan
Rousselot
Segment by Type
Hydrogels
Alginate Inks
Collagen-Based Inks
Segment by Application
Histology
Organ Transplants
Drug Testing and Development
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tissue Bioprinting Ink manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tissue Bioprinting Ink by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tissue Bioprinting Ink in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Tissue Bioprinting Ink Market Overview
1.1 Product Definition
1.2 Tissue Bioprinting Ink Segment by Type
1.2.1 Global Tissue Bioprinting Ink Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Hydrogels
1.2.3 Alginate Inks
1.2.4 Collagen-Based Inks
1.3 Tissue Bioprinting Ink Segment by Application
1.3.1 Global Tissue Bioprinting Ink Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Histology
1.3.3 Organ Transplants
1.3.4 Drug Testing and Development
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Tissue Bioprinting Ink Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Tissue Bioprinting Ink Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Tissue Bioprinting Ink Production Estimates and Forecasts (2019-2030)
1.4.4 Global Tissue Bioprinting Ink Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tissue Bioprinting Ink Production Market Share by Manufacturers (2019-2024)
2.2 Global Tissue Bioprinting Ink Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Tissue Bioprinting Ink, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Tissue Bioprinting Ink Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Tissue Bioprinting Ink Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Tissue Bioprinting Ink, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tissue Bioprinting Ink, Product Offered and Application
2.8 Global Key Manufacturers of Tissue Bioprinting Ink, Date of Enter into This Industry
2.9 Tissue Bioprinting Ink Market Competitive Situation and Trends
2.9.1 Tissue Bioprinting Ink Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tissue Bioprinting Ink Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tissue Bioprinting Ink Production by Region
3.1 Global Tissue Bioprinting Ink Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Tissue Bioprinting Ink Production Value by Region (2019-2030)
3.2.1 Global Tissue Bioprinting Ink Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Tissue Bioprinting Ink by Region (2025-2030)
3.3 Global Tissue Bioprinting Ink Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Tissue Bioprinting Ink Production by Region (2019-2030)
3.4.1 Global Tissue Bioprinting Ink Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Tissue Bioprinting Ink by Region (2025-2030)
3.5 Global Tissue Bioprinting Ink Market Price Analysis by Region (2019-2024)
3.6 Global Tissue Bioprinting Ink Production and Value, Year-over-Year Growth
3.6.1 North America Tissue Bioprinting Ink Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Tissue Bioprinting Ink Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Tissue Bioprinting Ink Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Tissue Bioprinting Ink Production Value Estimates and Forecasts (2019-2030)
4 Tissue Bioprinting Ink Consumption by Region
4.1 Global Tissue Bioprinting Ink Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Tissue Bioprinting Ink Consumption by Region (2019-2030)
4.2.1 Global Tissue Bioprinting Ink Consumption by Region (2019-2024)
4.2.2 Global Tissue Bioprinting Ink Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Tissue Bioprinting Ink Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Tissue Bioprinting Ink Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tissue Bioprinting Ink Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Tissue Bioprinting Ink Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tissue Bioprinting Ink Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Tissue Bioprinting Ink Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tissue Bioprinting Ink Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Tissue Bioprinting Ink Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Tissue Bioprinting Ink Production by Type (2019-2030)
5.1.1 Global Tissue Bioprinting Ink Production by Type (2019-2024)
5.1.2 Global Tissue Bioprinting Ink Production by Type (2025-2030)
5.1.3 Global Tissue Bioprinting Ink Production Market Share by Type (2019-2030)
5.2 Global Tissue Bioprinting Ink Production Value by Type (2019-2030)
5.2.1 Global Tissue Bioprinting Ink Production Value by Type (2019-2024)
5.2.2 Global Tissue Bioprinting Ink Production Value by Type (2025-2030)
5.2.3 Global Tissue Bioprinting Ink Production Value Market Share by Type (2019-2030)
5.3 Global Tissue Bioprinting Ink Price by Type (2019-2030)
6 Segment by Application
6.1 Global Tissue Bioprinting Ink Production by Application (2019-2030)
6.1.1 Global Tissue Bioprinting Ink Production by Application (2019-2024)
6.1.2 Global Tissue Bioprinting Ink Production by Application (2025-2030)
6.1.3 Global Tissue Bioprinting Ink Production Market Share by Application (2019-2030)
6.2 Global Tissue Bioprinting Ink Production Value by Application (2019-2030)
6.2.1 Global Tissue Bioprinting Ink Production Value by Application (2019-2024)
6.2.2 Global Tissue Bioprinting Ink Production Value by Application (2025-2030)
6.2.3 Global Tissue Bioprinting Ink Production Value Market Share by Application (2019-2030)
6.3 Global Tissue Bioprinting Ink Price by Application (2019-2030)
7 Key Companies Profiled
7.1 CELLINK
7.1.1 CELLINK Tissue Bioprinting Ink Corporation Information
7.1.2 CELLINK Tissue Bioprinting Ink Product Portfolio
7.1.3 CELLINK Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.1.4 CELLINK Main Business and Markets Served
7.1.5 CELLINK Recent Developments/Updates
7.2 PB Leiner
7.2.1 PB Leiner Tissue Bioprinting Ink Corporation Information
7.2.2 PB Leiner Tissue Bioprinting Ink Product Portfolio
7.2.3 PB Leiner Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.2.4 PB Leiner Main Business and Markets Served
7.2.5 PB Leiner Recent Developments/Updates
7.3 Organovo
7.3.1 Organovo Tissue Bioprinting Ink Corporation Information
7.3.2 Organovo Tissue Bioprinting Ink Product Portfolio
7.3.3 Organovo Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Organovo Main Business and Markets Served
7.3.5 Organovo Recent Developments/Updates
7.4 Humabiologics
7.4.1 Humabiologics Tissue Bioprinting Ink Corporation Information
7.4.2 Humabiologics Tissue Bioprinting Ink Product Portfolio
7.4.3 Humabiologics Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Humabiologics Main Business and Markets Served
7.4.5 Humabiologics Recent Developments/Updates
7.5 UPM Biomedicals
7.5.1 UPM Biomedicals Tissue Bioprinting Ink Corporation Information
7.5.2 UPM Biomedicals Tissue Bioprinting Ink Product Portfolio
7.5.3 UPM Biomedicals Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.5.4 UPM Biomedicals Main Business and Markets Served
7.5.5 UPM Biomedicals Recent Developments/Updates
7.6 Innoregen
7.6.1 Innoregen Tissue Bioprinting Ink Corporation Information
7.6.2 Innoregen Tissue Bioprinting Ink Product Portfolio
7.6.3 Innoregen Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Innoregen Main Business and Markets Served
7.6.5 Innoregen Recent Developments/Updates
7.7 Axolotl Biosciences
7.7.1 Axolotl Biosciences Tissue Bioprinting Ink Corporation Information
7.7.2 Axolotl Biosciences Tissue Bioprinting Ink Product Portfolio
7.7.3 Axolotl Biosciences Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Axolotl Biosciences Main Business and Markets Served
7.7.5 Axolotl Biosciences Recent Developments/Updates
7.8 Jellagen
7.8.1 Jellagen Tissue Bioprinting Ink Corporation Information
7.8.2 Jellagen Tissue Bioprinting Ink Product Portfolio
7.8.3 Jellagen Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Jellagen Main Business and Markets Served
7.7.5 Jellagen Recent Developments/Updates
7.9 Advanced BioMatrix (BICO)
7.9.1 Advanced BioMatrix (BICO) Tissue Bioprinting Ink Corporation Information
7.9.2 Advanced BioMatrix (BICO) Tissue Bioprinting Ink Product Portfolio
7.9.3 Advanced BioMatrix (BICO) Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Advanced BioMatrix (BICO) Main Business and Markets Served
7.9.5 Advanced BioMatrix (BICO) Recent Developments/Updates
7.10 RegenHU
7.10.1 RegenHU Tissue Bioprinting Ink Corporation Information
7.10.2 RegenHU Tissue Bioprinting Ink Product Portfolio
7.10.3 RegenHU Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.10.4 RegenHU Main Business and Markets Served
7.10.5 RegenHU Recent Developments/Updates
7.11 GeSIM
7.11.1 GeSIM Tissue Bioprinting Ink Corporation Information
7.11.2 GeSIM Tissue Bioprinting Ink Product Portfolio
7.11.3 GeSIM Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.11.4 GeSIM Main Business and Markets Served
7.11.5 GeSIM Recent Developments/Updates
7.12 CollPlan
7.12.1 CollPlan Tissue Bioprinting Ink Corporation Information
7.12.2 CollPlan Tissue Bioprinting Ink Product Portfolio
7.12.3 CollPlan Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.12.4 CollPlan Main Business and Markets Served
7.12.5 CollPlan Recent Developments/Updates
7.13 Rousselot
7.13.1 Rousselot Tissue Bioprinting Ink Corporation Information
7.13.2 Rousselot Tissue Bioprinting Ink Product Portfolio
7.13.3 Rousselot Tissue Bioprinting Ink Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Rousselot Main Business and Markets Served
7.13.5 Rousselot Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tissue Bioprinting Ink Industry Chain Analysis
8.2 Tissue Bioprinting Ink Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tissue Bioprinting Ink Production Mode & Process
8.4 Tissue Bioprinting Ink Sales and Marketing
8.4.1 Tissue Bioprinting Ink Sales Channels
8.4.2 Tissue Bioprinting Ink Distributors
8.5 Tissue Bioprinting Ink Customers
9 Tissue Bioprinting Ink Market Dynamics
9.1 Tissue Bioprinting Ink Industry Trends
9.2 Tissue Bioprinting Ink Market Drivers
9.3 Tissue Bioprinting Ink Market Challenges
9.4 Tissue Bioprinting Ink Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
CELLINK
PB Leiner
Organovo
Humabiologics
UPM Biomedicals
Innoregen
Axolotl Biosciences
Jellagen
Advanced BioMatrix (BICO)
RegenHU
GeSIM
CollPlan
Rousselot
Ìý
Ìý
*If Applicable.
